DRUG DISCOVERY APPROACHES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS ALZHEIMER'S DISEASE
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease examines the drug discovery process for neurodegenerative diseases by focusing specifically on Alzheimer's Disease and illustrating the paradigm necessary to ensure future research and treatment...
Saved in:
Other Authors: | |
---|---|
Format: | Book |
Language: | English |
Published: |
AMSTERDAM
ELSEVIER/ACADEMIC PRESS
2017
|
Subjects: | |
Online Access: | Click Here to View Status and Holdings. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000ntm a2200000#i 4501 | ||
---|---|---|---|
001 | wils-912269 | ||
005 | 201821510518 | ||
008 | 180315s2017 -UK a## ##001 #dENG#D | ||
020 | # | # | |a 9780128028100 |q hardback |
020 | # | # | |a 0128028106 |q hardback |
040 | # | # | |a YDX |d UiTM |e rda |
041 | 0 | # | |a eng |
060 | 0 | 0 | |a WT 155 |
090 | 0 | 0 | |a WT155 |b D7943 2017 |
245 | 0 | 0 | |a DRUG DISCOVERY APPROACHES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS |b ALZHEIMER'S DISEASE |c Edited by ADEBOYE ADEJARE |
264 | # | 1 | |a AMSTERDAM |b ELSEVIER/ACADEMIC PRESS |c 2017 |
264 | # | 4 | |c ©2017 |
300 | # | # | |a xvii, 290 pages |b illustrations |c 24 cm |
336 | # | # | |a text |2 rdacontent |
337 | # | # | |a unmediated |2 rdamedia |
338 | # | # | |a volume |2 rdacarrier |
504 | # | # | |a Includes bibliographical references and index |
520 | # | # | |a Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease examines the drug discovery process for neurodegenerative diseases by focusing specifically on Alzheimer's Disease and illustrating the paradigm necessary to ensure future research and treatment success. The book explores diagnosis, epidemiology, drug discovery strategies, current therapeutics, and much more to provide a holistic approach to the discovery, development, and treatment of Alzheimer's Disease. Through its coverage of the latest research in targeted drug design, preclinical studies, and mouse and rat models, the book is a must-have resource for all pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers working in this area. It illustrates why these drugs tend to fail at the clinical stage, and examines Alzheimer's Disease within the overall context of improving the drug discovery process for the treatment of other neurodegenerative disorders. |
546 | # | # | |a Text in English |
650 | # | 2 | |a Alzheimer Disease |x drug therapy |
650 | # | 2 | |a Drug Discovery |
650 | # | 2 | |a Neuroprotective Agents |x therapeutic use |
650 | # | 2 | |a Amyloid beta-Peptides |
700 | 1 | # | |a Adejare, Adeboye |d 1959- |e editor |
856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=912269 |